Next Article in Journal
Study of the Spatio-Temporal Differentiation of Factors Influencing Carbon Emission of the Planting Industry in Arid and Vulnerable Areas in Northwest China
Next Article in Special Issue
Dietary Folate Intake and Folic Acid Supplements among Pregnant Women from Southern Italy: Evidence from the “Mamma & Bambino” Cohort
Previous Article in Journal
Age and Sex Differences in the Use of Emergency Telephone Consultation Services in Saitama, Japan: A Population-Based Observational Study
Previous Article in Special Issue
Mothers’ Expectations and Factors Influencing Exclusive Breastfeeding during the First 6 Months
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Breastfeeding and the Risk of Infant Illness in Asia: A Review

1
College of Science, Health, Engineering and Education, Murdoch University, Murdoch, WA 6150, Australia
2
School of Public Health, Curtin University, Bentley, WA 6102, Australia
*
Authors to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(1), 186; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17010186
Submission received: 6 December 2019 / Revised: 23 December 2019 / Accepted: 24 December 2019 / Published: 26 December 2019
(This article belongs to the Special Issue Maternal and Early-Life Nutrition and Health)

Abstract

:
Infancy remains the most vulnerable period of human life for death, illness, and establishing a lifetime trajectory of growth and health. It is estimated that there are 5.3 million deaths under five years of age worldwide and approximately 800,000 lives could be saved by improving breastfeeding rates and duration. In Asia, an estimated 300,000–350,000 child deaths could be prevented with optimal breastfeeding and the majority would be under 12 months of age. We present a systematic review of studies of infection and breastfeeding in infants in Asia and further review interactions of selected infectious diseases and breastfeeding. Initially, 2459 records of possible interest were identified, 153 full text papers were reviewed in detail, and 13 papers describing diarrhoeal disease and/or acute respiratory tract infection were selected for inclusion in the review. Additional papers were selected to discuss specific diseases and their relationship to breastfeeding. The review found that a variety of methods were used with differing definitions of breastfeeding and diseases. Overall, breastfeeding when compared to the use of infant formula, is associated with significantly lower rates of diarrhoeal disease and lower respiratory tract infection, with a reduction of 50% or more to be expected, especially in infants under six months of age. The relationship between breastfeeding and specific diseases including measles and HTLV1 were reviewed. Breastfeeding reduces some disease rates, but there remain a few conditions where breastfeeding may be contra-indicated.

1. Introduction

The importance of nutrition for health has been acknowledged for millennia, since the days of Hippocrates [1]. However it is only in the last six decades that any significance has been given to the relationship between nutrition and infection. Understanding this relationship and implementing nutrition promotion programs has been instrumental in the substantial improvements in infant and child health made in the last few decades. In China, the largest nation in the region (and the world), in the past 50 years the infant mortality rate has fallen from 84 in 1000 live births to the current level of seven per 1000, a public health story demonstrating remarkable progress [2,3]. Widespread recognition of the importance of this relationship followed the publication of the landmark WHO monograph on the interactions of nutrition and infection in 1968 [4]. Scrimshaw has summarized the history of the development of this concept in the 20th century [5].
The association between breastfeeding and infection was studied in the 1950s and Scrimshaw includes a description of a survey completed in the Punjab by Hartemann in 1961 [4]. In this study the infant mortality rate was eight times greater in infants “artificially” fed from birth compared to those who were breastfed. Beginning in the late 1950s, the Institute for Nutrition of Central America and Panama (INCAP) sponsored studies in Guatemala which added further supporting evidence to this concept [6].
The lack of randomized control trials of breastfeeding means that studies of breastfeeding reach rarely the highest standards of evidence required in systematic reviews. The major difficulty in undertaking a review of breastfeeding is that it is unethical to undertake randomized controls. The known advantages of breastmilk make it impossible to randomize infants into a control group [7]. The Promotion of Breastfeeding Intervention Trial PROBIT trial is the closest that we have to the large randomized controlled trials that are usually found in systematic reviews of pharmaceutical therapies. The PROBIT study was a cluster-randomized controlled trial of a health promotion intervention to promote exclusive breastfeeding. It commenced in Belarus in 1996 with the recruitment of 17,046 mother–infant dyads [8]. The hospitals were randomized to receive a health education training program based on the baby-friendly hospital initiative (BFHI), which was designed to increase breastfeeding duration and the proportion of mothers breastfeeding exclusively. However as recruitment did not commence until the first month postpartum, only mothers who had initiated breastfeeding were enrolled, and some of these would have already received some infant formula and hence were misclassified as exclusively breastfed as shown in the study by Mathias et al. [9]. There was no control group of formula fed infants and hence it was a cluster trial of health promotion to extend breastfeeding duration [10,11]. Despite limitations, the study has been very useful and has shown, for example, the value of the BFHI in prolonging breastfeeding duration, the role of breastfeeding in reducing gastrointestinal infections, and that cognitive development is related to breastfeeding quantity and quality [8]. There are no similar large-scale studies available in Asia for comparison with PROBIT. Because if this limitation, studies on the importance of breastfeeding rely on the accumulation of observational studies.
Conclusions on the benefits of breastfeeding for protection against infection have relied on the accumulation of studies mostly from South America and the African continent, with a limited number of studies from Europe and other higher income regions. Typical of observational studies of breastfeeding and infection is the cohort study of 4164 in the Netherlands where breastfeeding was associated with a reduction in morbidity and mortality in children less than five years of age, particularly those exclusively breastfed up to four and six months of age [12]. There have been no recent reviews of studies of breastfeeding and infection specifically in Asia.
The aim of this study was to undertake a systematic review of breastfeeding and infection in Asia. Studies of acute respiratory infections and diarrhoeal disease with adequate descriptions of breastfeeding definitions were tabulation. Information was compiled on other infant infections and breastfeeding.

2. Materials and Methods

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol was followed for this review and the search strategy results are shown in Figure 1 [13].
Keywords used for searching were: breastfeeding, infant feeding, infant formula, illness, or infection. These keywords were combined with Asia or China or Korea or Japan or Taiwan or Laos or Cambodia or Vietnam or Philippines or Malaysia or Singapore or Myanmar or Indonesia or Papua New Guinea or India or Bangladesh or Pakistan or Maldives.
The following comprehensive English-language databases were used to search for studies: Web of Knowledge, PubMed, Science Direct, and Proquest. Searches were limited to infants (less than 12 months old). Papers published 1990 or later were included. A sample size of a minimum 200 was needed for inclusion in the review. For example, one classic study from Indonesia had a sample of only 33 infants and was therefore excluded [14].
A total of 166 papers were identified that met the inclusion criteria, and this was reduced to 140 after duplicates were removed. The quality assessment of each study included an assessment of the definitions of breastfeeding used, the size and selection of the sample, and the length of the recall time to the feeding mode and morbidity. The ethical difficulties of research into breastfeeding, only observational studies, means that no studies were of the highest quality rating. The types of study: cross-sectional, cohort, or case-control are listed in Table 1.
A number of studies were excluded due to a lack of standardised definitions or measurements or long recall periods. Information about breastfeeding is more accurate if it is recorded in a cohort study with a time interval as short as practical. Examples of studies excluded are given here to indicated the type of shortcomings encountered in published research studies on breastfeeding:
In a study in Japan, mothers were interviewed when their infants were admitted to hospital. The sample was aged between 6 and 18 months and mothers were asked to recall feeding methods soon after birth. In this study the recall period was too long and the variation in the infants age created further uncertainty in the recall length [15].
In a 4-year prospective study to determine risk factors for severe community acquired pneumonia in children in Southern China breastfeeding was measured as a binomial variable, yes or no. In this study 100% were classified as “breastfeeding” and hence no effect of infant feeding method could be measured [16]. This study ignored the effect that the introduction of formula feeds at an early age can have on immune responses and the composition of the microbiome.
A cross-sectional study in India of 3671 children under 5 years of age. Breastfeeding was not measured adequately as mothers were retrospectively questioned up until five years after the event and no definition of exclusive breastfeeding was given in the paper [17].
A study by Perrera in Sri Lanka included 285 cases and 58 controls. Mothers were interviewed to determine how long the infants/children had been exclusively breastfed. The authors concluded that EBF infants had lower odds of developing diarrhoeal or respiratory disease [18]. However, the age at interview ranged from 6 months to 12 years, resulting in a varying length of recall with the likelihood of inaccurate results and this study was therefore excluded.
In India, a case control study of children aged 0–5 years included 300 hospital cases and 300 community controls involved long and varied periods of recall of breastfeeding details. Univariate results for the ‘use of prelacteal feeds’ and ‘appropriate age of weaning’ are given, without defining exactly what was measured. No results for <12 months given A significant association was found between ARI and lack of breastfeeding, nutritional status, immunization status, delayed weaning, prelactal feeding, living in overcrowded conditions, mothers’ literacy status, low birth weight, and prematurity [19].
No ethics approval was required for this paper as it is a review of previously published studies. Each paper included was a review to ensure that it contained mention of ethics clearance. The results of the studies for respiratory and diarrhoeal diseases were tabulated. It was not possible to undertake a meta-analysis due to the differences in methodology and varying definitions of exposure and outcomes. There were insufficient studies for other infectious conditions to be included in the table, but where adequate information is available, they are mentioned individually.

3. Results

The selection process for the 13 studies included in the review produced eight cohort, four cross-sectional, and one case-control study, as detailed in Figure 1.
In almost all of the published studies, breastfeeding was associated with a reduction in the risk of developing an acute respiratory tract infection or diarrhoeal disease. This includes both illness episodes requiring hospital admission or those managed in the community. The reduction in the incidence of these infections is in the order of 50–60% when comparing exclusive or predominant breastfeeding with the use of formula. A number of studies were excluded because of a deficient methodology, but even in those included, standard definitions of breastfeeding were frequently not used. Outcomes, intervals between observations, and definitions varied between studies, making it impossible to undertake a meta-analysis. Nevertheless, the direction of the results showed a strong association between breastfeeding and lower rates of infection in Asia. The studies included in this review are detailed in Table 1.
The study by Yoon in the Philippines used infant deaths as the endpoint. Because of this the numbers were small and showed an effect for deaths due to diarrhoea (24 deaths), diarrhoea and ALRI combined (14 deaths), but did not show an effect of breastfeeding on ALRI by itself (18 deaths) [22].
In a study from Chengdu, China breastfeeding was protective, but if solid foods were introduced before 4 months, the RR of developing a lower respiratory tract infection was 2.996 (1.298–6.916) [20]. This result confirms the importance of the WHO recommendation not to introduce complementary foods before six months of age [34].
The protective effect of breastfeeding on preventing hospital admission for diarrhoeal disease and acute respiratory infection on infants is detailed in Table 1. All of the identified studies showed a protective effect, except one. Typical of the results from a cohort study was an odds ratio for diarrhoeal disease of 0.37 (0.15, 0.88) and 0.39 (0.20, 0.75) for acute respiratory illness [25]. The other studies listed use a number of different methodologies, age ranges, and endpoints, but the direction of the effect is the same.

3.1. Breastfeeding and Specific Infections

Breastfeeding may transmit a number of communicable diseases, including HIV, hepatitis, cytomegalic virus, HTLV1, Ebola, Zika, and the Flavi viruses. Brucellosis has also been reported [35]. The WHO has provided a list of infections where breastfeeding may be contra-indicated or require specific management [36]. However, because of the advantages of breastfeeding, in many cases, particularly in resource-poor communities, the benefits of breastfeeding may outweigh the risks inherent in the use of formula. Infectious conditions included in the WHO advice include:
Breast abscess: breastfeeding should continue on the unaffected breast; feeding from the affected breast can resume once treatment has started.
Hepatitis B: infants should be given hepatitis B vaccine, within the first 48 h or as soon as possible thereafter.
Tuberculosis: mother and baby should be managed according to national tuberculosis guidelines [36].
Because of the advantages of breastfeeding, in many cases, particularly in resource poor communities, the benefits of breastfeeding will be greater than the risk of breastfeeding in some of the specific infections included above [36]. While the WHO has given some reasons for not breastfeeding, in some cases in the decade since the publication of these guidelines, advances in treatment have allowed breastfeeding to continue. For example, further information on the transmission through breastmilk and prevalence of HIV, HTLV1, and Zika virus has become available [37].

3.1.1. Measles

WHO has advocated for the elimination of measles through widespread vaccination and public health control measures. Measles vaccination and improved nutrition resulted in a decline in measles deaths of 80% between 2000 and 2017 worldwide. In this period measles vaccination prevented an estimated 21.1 million deaths [38]. However, measles is still a major cause of death in children and there were 110,000 measles deaths globally, with many more infants and children suffering from complications of the disease. In the 12 months to 28 November 2019, the WHO reported 205,000 cases of measles in the SEARO and WPRO regions [39].
Recently, there has been a resurgence in measles cases in many countries, including relatively isolated Pacific Islands. Tonga with a population of only 104,000 has had 3728 cases and 53 infant deaths this year [40]. A mass vaccination campaign has been started and 58,000 vaccinated to 1 December 2019. This is reminiscent of the time when Europeans first sailed into the Pacific centuries ago and devastated many islands with measles outbreaks [41].
After birth, circulating maternal antibodies provide some protection against measles and this is the basis for the postponement of measles vaccination until later in the first year of life [42]. Breastfeeding provides some protection against measles, but vaccination is required for maximum protection [43]. Early initiation and maintenance of exclusive breastfeeding up until 6 months provides protection for infants with a possible beneficial effect on the vaccine response [44]. After measles infections resistance to other infections decreases often leading to a downward spiral of poor health [45]. Susceptible women who are breastfeeding should be vaccinated with MMR vaccine [46].

3.1.2. Zika Virus

Zika virus infection during pregnancy may result in neurological abnormalities, and the virus and its vector have been reported in the Asian region [47]. The Zika virus can be found in human milk, but a review found no documented studies of long-term complications in infants [48]. The World Health Organization recommends that the benefits of breastfeeding for the infant and mother outweigh any potential risk of Zika virus transmission through breast milk [49].

3.1.3. HIV Infection

In Asia the majority of mothers are tested for STDs, HIV and Hepatitis B during their antenatal visits. The estimated rates of antenatal care are East Asia 96.5%, South East Asia 76.4%, South Asia 50% [50]. Mothers are usually commenced on anti-retroviral therapy (ART) as soon as a diagnosis is made. The use of ART allows breastfeeding to commence and continue with all of the advantages this brings to mother an infant [51]. Breastfeeding should be exclusive until six months before any other fluids or complementary foods are given. This will maintain an optimum microbiome which will contribute resistance to HIV. However, in many Asian countries, if the mother is HIV positive, the infant is started on infant formula after birth as, for example, in Vietnam [52].

3.1.4. Hepatitis B

Hepatitis B remains a common infection that is tested for antenatally in mothers. Despite the high rate of Hepatitis B in Asia, it is estimated that just over one third of infants are vaccinated at birth, despite its proven efficacy [53]. In Hangzhou, China, a cohort study (n = 638) identified 6% of the mothers as being Hepatitis B positive. At one month post-partum, these mothers had a significantly lower rate of ‘any breastfeeding’ compared to non-infected mothers, 62% and 92% respectively, as many had been encouraged by health workers not to breastfeed and to use formula [54]. However, breastfeeding by mothers and infants who have been vaccinated was not associated with HBV infection in the children. Under the recommended prophylaxis, breastfeeding is not a risk factor for mother-to-child transmission of HBV and therefore, clinicians should encourage HBV-infected mothers to breastfeed their infants [55].

3.1.5. Hepatitis C

Globally it is estimated by the WHO that there are 71 million cases of chronic hepatitis C infection world-wide, but other estimates are double this amount [56,57]. Hence, it is not uncommon for a hepatitis C positive mother to breastfeed. Co-infection of hepatitis C and HIV increases the risk of preterm labour [58]. The Center for Disease Control (CDC) recommends that there should be no restrictions on breastfeeding by mothers who are hepatitis C positive [59].

3.1.6. Human T Cell Leukemia Virus (HTLV)

There are an estimated 5–10 million infected persons worldwide infected with HTLV1, and in Asia, infection appears to be more prevalent in Japan and Central Australia [60,61]. It is transmitted by sexual contact, blood transfusions or breastfeeding. The prevalence of the virus is as high as 40% in some outback communities in Australia. While this population has higher rates of some cancers, there is not a large difference in leukemia rates compared to the total Australian population [62]. Other conditions, including chronic renal disease, may also be associated with this infection [60,63]. Where a mother is a known carrier of HTLV, breastfeeding is generally not recommended, but further research is required to establish if this is always the best option.

3.1.7. Helicobacter Pylori

Helicobacter pylori infection remains common throughout Asia and can be acquired at an early age [64]. Reviews of the world-wide distribution of H. pylori sero-positive responses, reported rates from Asia of up to 50% in Malaysia, in Japan 24–29% and in Korea 42% [65,66]. In China, H pylori prevalence among symptomatic children fell from 25.6% to 12.8% between 2005 and 2017 [65]. There have been several studies on associations of breastfeeding and Helicobacter infection. The majority of studies support a preventive association between breastfeeding and infection in infancy [67,68]. However, infection rates increase throughout childhood, suggesting that the protective effect of breastfeeding is limited to the early years of life. Further research is required in this area.

3.1.8. Malaria

Malaria remains an important infection in Asia and can be very difficult to treat in areas where resistance to antimalarial treatment is high. We did not locate any studies from Asia, but studies from Africa suggest that breastfeeding may offer some protection against malaria. In a cross-sectional study from Cameroon (n = 1227), children who had been exclusively breastfed had significantly lower (P < 0.001) prevalence of malaria parasite (16.2%) than those not breastfed at all (61.3%) [69]. In a further study from the Democratic Republic of the Congo, 137 EBF infants and 358 non-EBF infants were assessed for fever and malaria infection by polymerase chain reaction (PRC) at six months of age. EBF was associated with a reduced risk of clinical malaria (OR = 0.13; 95% CI = 0.00–0.80), suggesting a protective effect of EBF against malaria [70]. An analysis of stool samples and malaria (PCR) from Mali found that a diverse microbiome was associated with a lower risk of falciparum malaria infection [71]. In the age of chemo-resistance, particularly the increasing rates of artemisinin resistance in Asia, breastfeeding could be important, perhaps as an adjunct to partially effective malaria vaccines. This is a further reason to avoid the unnecessary use of antibiotics and the disruption this causes to the microbiome.

3.1.9. Neonatal Sepsis

A review of infant deaths in Asia found that while overall infant mortality has declined, neonatal infections and deaths have not declined as rapidly and remain a continuing problem [72]. In Bangladesh, neonatal sepsis is the cause of 24% of neonatal deaths, over 65% of which occur in the early-newborn stage (0–6 days). Only 50% of newborns in Bangladesh initiated breastfeeding within 1 h of birth. The early initiation of breastfeeding, within one hour of birth, was associated with the lowest rates of infection [73]. In a meta-analysis of neonatal mortality and breastfeeding, including five out of 10 studies from Asia, the pooled evidence indicated substantial benefits from effective promotion of early initiation of breastfeeding and exclusive breastfeeding during the first month of life [74]. In neonatal intensive care units necrotising enterocolitis (NEC) remains a continuing problem. Wherever possible breastmilk is given to the infant and reduces the incidence of NEC [75,76]. A meta-analysis suggests that unlike breastmilk, donor human milk is not effective in the prevention of NEC [77]. Continuing research is required on effectiveness and mechanisms.

3.1.10. Breastfeeding and Infant Vaccination

Heading the list of the ten greatest public health achievements of the 20th century is “progress in the development of new vaccines and their promotion across the globe”. An example of the powerful nature of vaccination as a public health measure was the elimination of smallpox, a major achievement made possible only by targeted vaccination [78]. Vaccination, along with the promotion of breastfeeding, remains the most important public health intervention against infection in infants and children. There are a number of important public health questions about the relationship between vaccination and breastfeeding:
Does breastfeeding increase or decrease response to and effectiveness vaccines?
Does vaccination of mothers prevent illness in infants through the transfer of antibodies and other factors to the infant across the placenta or in breastmilk?
There are a number of biological challenges to to the effective use of, and response to vaccines in lower income countries. Studies on twins show variation in genetics as an important factor to the response to vaccination [79]. Other factors include early life exposure to infection and other vaccines, maternal factors, breastfeeding, age, nutritional status, and other environmental factors [79]. In a review of studies of breastfeeding and vaccinations in infants, Dorea and colleagues found that early breastfeeding initiation, with exclusive breastfeeding to six months, provided maximum protection to infants and a possible beneficial effect on the vaccine responses [44]. Cell-mediated immune response to BCG (Bacille Calmette-Guerin) vaccine given at birth, but not at after one month, was significantly enhanced by breastfeeding. Also, antibody level responses to oral polio vaccine and vaccination with diphtheria and tetanus toxoid were increased in breastfed infants compared to formula-fed. Breastfed infants immunized with Haemophilus influenzae type B, show higher antibody levels at 7 months and 12 months [44]. When vaccines are given by injection breastfeeding provides a significant amount of pain relief and calms the infant [80,81]. More research is needed in Asia on the relationship between breastfeeding and vaccine response.

3.1.11. Maternal Vaccination

During their antenatal visits, mothers have their vaccination records assessed and are vaccinated where necessary. Maternal vaccination is the only time that vaccination can benefit two generations from a single input, with the possible exception of live polio vaccine [82]. A study in Beijing found that the seroprevalence of maternal and cord antibodies specific for diphtheria, tetanus, pertussis, measles, mumps, and rubella were lower than expected and the authors recommended a vaccination program before pregnancy [83]. Breastfeeding after maternal immunisation during pregnancy has been shown to promote transplacental IgG transfer and after birth, IgA is found in breastmilk. Both mechanisms provide immunological protection to the newborn [84,85]. Some protection from antibodies in breastmilk lasts as long as breastfeeding is continued, but as the infants’ digestive systems develop, denaturation of some antibodies may occur. Other non-specific factors may remain active. Further research is required to assess the extent to which breastmilk antibodies may promote or reduce the effectives of infant vaccination. Influenza vaccine is recommended during pregnancy to protect the newborn and no complications have been reported [86,87,88].
Neonatal tetanus, which is a devastating, infection provides a good case study of the benefits of maternal vaccination. Any health workers who have seen an infant suffering from neonatal tetanus in a low resource setting will never forget the experience. In Papua New Guinea, in the district of Maprik, the infant mortality rate was around 300 with one third due to neonatal tetanus [89]. Implementation of a program of two injections of tetanus toxoid during pregnancy eliminated the problem. However, recently, a shortage of resources and a decline rural health services, has resulted in the disease reappearing [90]. Worldwide, it is estimated that 58,000 neonates from 24 countries still die unnecessarily from the disease every year [91].

3.1.12. Infection from Infant Formula

The review by the US Surgeon General has detailed the increased risk to infants of infection from the use of infant formula instead of breastfeeding [92]. Infant formula may be contaminated by incorrect preparation or storage. In addition, a known contaminant of formula powder is Chronobacter (formerly Enterobactor) sakazakii. This bacteria is found primarily in dry and dehydrated foods with low water activity, such as herbal teas, starches, and in powdered infant formula [93]. In formula-fed infants it can occasionally cause infections and fatal neonatal cases have been reported from Japan [94].

4. Discussion

This review confirms that the same protective effects of breastfeeding against acute respiratory infection and diarrhoeal disease found in previous reviews in other parts of the world, are also evident in studies from Asia. UNICEF found that the major causes of death worldwide under 12 months of age are pneumonia and diarrhoeal disease [95]. In 2010, diarrhoeal diseases accounted for 11% of the estimated 7.6 million under-five deaths, globally. In Bangladesh, 11% of all under-five deaths (n = 182,936) were due to diarrhea [96]. There was a lower overall rate of diarrhoea in breastfed infants and non-breastfed had a higher rate of rota virus infection in infants 9–12 months [96]. The results for the reduction in deaths by promoting breastfeeding is similar to major reviews from other parts of the world [92,97].
In the WHO regions of East Asia and Pacific, there were 462,000 deaths under the age of five years, including 230,000 neonatal deaths, which was 50% of all under-five deaths. In the WHO South Asia region, there were 1,475,000 deaths under five years and the 909,000 neonatal deaths were 62% of all under five deaths. The population of the Asian countries included in this review was 3.84 billion in 2018. There were 60.3 million births and 1.2 million deaths under one year of age [98]. The weighted infant mortality rate for Asia has declined from 64.5 to 20.1 per 1000 live births between 2000 and 2018. In 2015, it was estimated that improved breastfeeding practices would prevent 823,000 annual deaths in children younger than five years of age and 20,000 annual deaths in women caused by breast cancer [99]. Extrapolating the data from this study, it is estimated that 300,000–350,000 child deaths could be prevented with optimal breastfeeding and the majority would be under 12 months of age.
The exploration of links between nutrition and infection and breastfeeding and infection has progressed during the past six decades, and pioneered the relationship between nutrition and infection. Early workers in the field included Jelliffe, Scrimshaw, and Morley, the latter seeking to emphasise the importance of nutrition to all community health workers [4,100]. In 1986, Ebrahim lamented the decline in breastfeeding worldwide, described breastfeeding as a valuable resource, and gave estimates of value of breastmilk in the USA, Indonesia and Tanzania [101]. He suggested that clinicians and public health workers should be strong advocates for breastfeeding and the control of formula. Since then, much further work has established breastfeeding as the most important link in the nutrition/infection chain of causation. However, despite the importance of breastfeeding being actively promoted by the WHO and UNICEF through research and advocacy, unfortunately, sales of formula continue to increase.
There are numerous bioactive components of breastmilk that contribute to the overall immunological activity of breastmilk, including antibodies, non-specific anti-infective agents, probiotics and white cells, inhibitors of microbiological activity, probiotic bacteria and prebiotic factors, and human cells, leucocytes and lymphocytes [102,103,104,105]. These components of breastmilk provide the mechanism for protection against infection, particularly in the first few months and throughout the breastfeeding period. There is some variation in samples from different parts of the world, although no Asian mothers were included in this study and the relationships with the epidemiology of infection are unclear [106]. Many epidemiological studies and reviews have confirmed the protective role of breastfeeding against infection. [92,97,107,108,109].
Once a child contracts an infection, it interferes with nutrition and metabolism, and children are more likely to become undernourished and subsequently to contract further infections [110]. One infection is likely to be followed by another and in the MAL-ED eight-country cohort study, a recent episode of diarrhoea was associated with a higher risk of further episodes of diarrhoea, RR 1.10 (1.04, 1.16), and with higher risk of acute lower respiratory tract infection in the following 3–5-months RR 1.23 (1.03, 1.47) [33].
The microbiome of the infant is important for the development of the immune system, nervous system, and growth [111]. Later in life the microbiome has an important role in reducing chronic disease and preventing obesity [112,113]. Breastfeeding has a very important role in the establishment of a healthy microbiome [114]. If antibiotics are given to treat infections, especially if repeatedly, this can change the microbiome. Dysbiosis of the microbiome is associated with many acute and chronic conditions.
The role of breastfeeding in protecting against infection has been emphasized in this review. However promoting breastfeeding has also been shown to reduce malnutrition, including poor growth and stunting worldwide [115]. While this review has emphasized the importance of breastfeeding in Asia, the benefits of breastfeeding in reducing infection rates also apply in higher income countries. When summarizing the results of a European cohort study the authors stated that their findings support health policy strategies to promote exclusive breastfeeding for at least 4 months, but preferably six months [12,116].
Despite the overwhelming evidence for breastfeeding offering protection against infection there are increasing sales of infant formula. One of the most important questions related to the implementation of the Sustainable Development Goals is how to increase breastfeeding for all infants [3]. More needs to be done to enforce the standards of the Baby Friendly Hospital Initiative and the WHO Code on the Marketing of Breastmilk Substitutes [108,117,118]. Skin to skin contact between mother and infant within 30–60 min of birth is recommended by UNICEF and WHO and has been shown to improve breastfeeding rates [119]. A review of this practice found considerable variation in the implementation of this practice with rates as low as 9.6% in the Philippines and up to 91% in Singapore [120]. Rates of early contact were much lower in infants delivered by caesarean section in Asia, but the difference was smaller in some Australian studies. Throughout Asia, more effort needs to be given to improve breastfeeding rates as an important step in improving health outcomes and in achieving the Sustainable Development Goals.
There are several limitations that must be taken into account when considering the results of this review. Ethical restraints have precluded the availability of RCTs and reviews rely only on observational studies. Nevertheless the number of observations increases the quality of the conclusion. In future it may be possible to develop biomarkers or detailed microbiome DNA profiles that would allow ore definitive conclusions. A further constraint is the variability in the definitions used. Very few studies used strict definitions of exclusive breastfeeding.
The lack of randomized controlled trials has meant that the quality of evidence is not ranked highly in the hierarchy of epidemiological studies. However, the sheer number of studies, the lack of any complications from breastfeeding, and the place of breastfeeding means that its importance cannot be understated. Not enough consideration has been given to the risks of introduction of formula or other foods [121]. These risks were well documented in the Surgeon General’s report.

5. Conclusions

This review provides details of studies of breastfeeding and infection in Asia. The results show that a minimum 50% reduction of infection rates in infants who are fully breastfed can be expected in the first six months of life. This will result in a significant reduction in costs to the health system and families. The review confirms the results of studies in other regions of the world. There are many shortcomings in studies of breastfeeding, and particular emphasis should be placed on the use of standard definitions. Further, health promotion efforts and environmental change are required to increase the prevalence of breastfeeding.

Author Contributions

Both authors contributed equally to development of the concept, literature search, analysis and writing of the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

The authors acknowledge the support of many colleagues at their home universities and across the Asia Pacific region. We also acknowledge the assistance we have received from thousands of mothers in our projects in the region during five decades of research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. De Luca, L.M.; Norum, K.R. Scurvy and cloudberries: A chapter in the history of nutritional sciences. J. Nutr. 2011, 141, 2101–2105. [Google Scholar] [CrossRef] [PubMed]
  2. UNICEF. State of the World’s Children 2017; Comunications Division UNICEF: New York, NY, USA, 2017. [Google Scholar]
  3. Binns, C.; Lee, M.K.; Low, W.Y.; Zerfas, A. The Role of Public Health Nutrition in Achieving the Sustainable Development Goals in the Asia Pacific Region. Asia Pac. J. Public Health Asia Pac. Acad. Consort. Public Health 2017, 29, 617–624. [Google Scholar] [CrossRef] [PubMed]
  4. Scrimshaw, N.S.; Taylor, C.E.; Gordon, J.E. Interactions of nutrition and infection. Monogr. Ser. World Health Organ. 1968, 57, 3–329. [Google Scholar] [PubMed]
  5. Scrimshaw, N.S. Historical concepts of interactions, synergism and antagonism between nutrition and infection. J. Nutr. 2003, 133, 316S–321S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Gordon, J.E.; Ascoli, W.; Mata, L.J.; Guzman, M.A.; Scrimshaw, N.S. Nutrition and infection field study in Guatemalan villages, 1959–1964. VI. Acute diarrheal disease and nutritional disorders in general disease incidence. Arch. Environ. Health 1968, 16, 424–437. [Google Scholar] [CrossRef]
  7. Binns, C.; Lee, M.K.; Kagawa, M. Ethical Challenges in Infant Feeding Research. Nutrients 2017, 9, 59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Kramer, M.S.; Chalmers, B.; Hodnett, E.D.; Sevkovskaya, Z.; Dzikovich, I.; Shapiro, S.; Collet, J.P.; Vanilovich, I.; Mezen, I.; Ducruet, T.; et al. Promotion of Breastfeeding Intervention Trial (PROBIT): A randomized trial in the Republic of Belarus. JAMA 2001, 285, 413–420. [Google Scholar] [CrossRef]
  9. Mathias, J.G.; Zhang, H.; Soto-Ramirez, N.; Karmaus, W. The association of infant feeding patterns with food allergy symptoms and food allergy in early childhood. Int. Breastfeed J. 2019, 14, 43. [Google Scholar] [CrossRef] [Green Version]
  10. Patel, R.; Oken, E.; Bogdanovich, N.; Matush, L.; Sevkovskaya, Z.; Chalmers, B.; Hodnett, E.D.; Vilchuck, K.; Kramer, M.S.; Martin, R.M. Cohort profile: The promotion of breastfeeding intervention trial (PROBIT). Int. J. Epidemiol. 2014, 43, 679–690. [Google Scholar] [CrossRef] [Green Version]
  11. Martens, P.J. What do Kramer’s Baby-Friendly Hospital Initiative PROBIT studies tell us? A review of a decade of research. J. Hum. Lact. 2012, 28, 335–342. [Google Scholar] [CrossRef]
  12. Duijts, L.; Jaddoe, V.W.V.; Hofman, A.; Moll, H.A. Prolonged and Exclusive Breastfeeding Reduces the Risk of Infectious Diseases in Infancy. Pediatrics 2010, 126, E18–E25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Available online: http://www.prisma-statement.org/ (accessed on 11 November 2017).
  14. Launer, L.J.; Habicht, J.P.; Kardjati, S. Breast-feeding protects infants in Indonesia against illness and weight-loss due to illness. Am. J. Epidemiol. 1990, 131, 322–331. [Google Scholar] [CrossRef] [PubMed]
  15. Yamakawa, M.; Yorifuji, T.; Kato, T.; Inoue, S.; Tokinobu, A.; Tsuda, T.; Doi, H. Long-Term Effects of Breastfeeding on Children’s Hospitalization for Respiratory Tract Infections and Diarrhea in Early Childhood in Japan. Matern. Child Health J. 2015, 19, 1956–1965. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, Q.L.; Guo, Z.Q.; Bai, Z.J.; MacDonald, N.E. A 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China. Pediatric Pulmonol. 2013, 48, 390–397. [Google Scholar] [CrossRef] [PubMed]
  17. Gothankar, J.; Doke, P.; Dhumale, G.; Pore, P.; Lalwani, S.; Quraishi, S.; Murarkar, S.; Patil, R.; Waghachavare, V.; Dhobale, R.; et al. Reported incidence and risk factors of childhood pneumonia in India: A community-based cross-sectional study. BMC Public Health 2018, 18, 1111. [Google Scholar] [CrossRef] [PubMed]
  18. Perera, B.J.C.; Ganesan, S.; Jayarasa, J.; Ranaweera, S. The impact of breastfeeding practices on respiratory and diarrhoeal disease in infancy: A study from Sri Lanka. J. Trop. Pediatrics 1999, 45, 115–118. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Taksande, A.M.; Yeole, M. Risk factors of Acute Respiratory Infection (ARI) in under-fives in a rural hospital of Central India. J. Pediatric Neonatal Individ. Med. 2016, 5, e050105. [Google Scholar] [CrossRef]
  20. Yu, C.; Binns, C.W.; Lee, A.H. Comparison of breastfeeding rates and health outcomes for infants receiving care from hospital outpatient clinic and community health centres in China. J. Child Health Care 2016, 20, 286–293. [Google Scholar] [CrossRef]
  21. Li, S.S.; Yue, A.; Abbey, C.; Medina, A.; Shi, Y.J. Breastfeeding and the Risk of Illness among Young Children in Rural China. Int. J. Environ. Res. Public Health 2019, 16, 136. [Google Scholar] [CrossRef] [Green Version]
  22. Yoon, P.W.; Black, R.E.; Moulton, L.H.; Becker, S. Effect of not breastfeeding on the risk of diarrheal and respiratory mortality in children under 2 years of age in Metro Cebu, The Philippines. Am. J. Epidemiol. 1996, 143, 1142–1148. [Google Scholar] [CrossRef] [Green Version]
  23. Raheem, R.A.; Binns, C.W.; Chih, H.J. Protective effects of breastfeeding against acute respiratory tract infections and diarrhoea: Findings of a cohort study. J. Paediatr. Child Health 2017, 53, 271–276. [Google Scholar] [CrossRef] [PubMed]
  24. Cai, L.; Yu, P.; Zhang, Y.M.; Yang, X.G.; Li, W.J.; Wang, P.Y. Effect of feeding pattern on infant illness in Chinese cities. Public Health Nutr. 2016, 19, 1252–1259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Hanieh, S.; Ha, T.T.; Simpson, J.A.; Thuy, T.T.; Khuong, N.C.; Thoang, D.D.; Tran, T.D.; Tuan, T.; Fisher, J.; Biggs, B.A. Exclusive breast feeding in early infancy reduces the risk of inpatient admission for diarrhea and suspected pneumonia in rural Vietnam: A prospective cohort study. BMC Public Health 2015, 15, 1166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Hengstermann, S.; Mantaring, J.B.V.; Sobel, H.L.; Borja, V.E.; Basilio, J.; Iellamo, A.D.; Nyunt-U, S. Formula Feeding Is Associated with Increased Hospital Admissions Due to Infections Among Infants Younger Than 6 Months in Manila, Philippines. J. Hum. Lact. 2010, 26, 19–25. [Google Scholar] [CrossRef] [PubMed]
  27. Arifeen, S.; Black, R.E.; Antelman, G.; Baqui, A.; Caulfield, L.; Becker, S. Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums. Pediatrics 2001, 108, E67. [Google Scholar] [CrossRef] [Green Version]
  28. Khan, S.M.; Speizer, I.S.; Singh, K.; Angeles, G.; Twum-Danso, N.A.Y.; Barker, P. Does postnatal care have a role in improving newborn feeding? A study in 15 sub-Saharan African countries. J. Glob. Health 2017, 7, 020506. [Google Scholar] [CrossRef] [PubMed]
  29. Khan, M.N.; Islam, M.M. Effect of exclusive breastfeeding on selected adverse health and nutritional outcomes: A nationally representative study. BMC Public Health 2017, 17, 889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Mihrshahi, S.; Ichikawa, N.; Shuaib, M.; Oddy, W.; Ampon, R.; Dibley, M.J.; Kabir, A.K.; Peat, J.K. Prevalence of exclusive breastfeeding in Bangladesh and its association with diarrhoea and acute respiratory infection: Results of the multiple indicator cluster survey 2003. J. Health Popul. Nutr. 2007, 25, 195–204. [Google Scholar] [PubMed]
  31. Mihrshahi, S.; Oddy, W.H.; Peat, J.K.; Kabir, I. Association between infant feeding patterns and diarrhoeal and respiratory illness: A cohort study in Chittagong, Bangladesh. Int. Breastfeed. J. 2008, 3, 28. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Panda, S.; Deb, A.K.; Chawla-Sarkar, M.; Ramamurthy, T.; Ganguly, S.; Pradhan, P.; Chakraborty, A.; Desai, S.; Gupte, M.D.; Dhere, R. Factors associated with diarrhoea in young children and incidence of symptomatic rotavirus infection in rural West Bengal, India. Epidemiol. Infect. 2014, 142, 1848–1858. [Google Scholar] [CrossRef]
  33. Richard, S.A.; McCormick, B.J.J.; Seidman, J.C.; Rasmussen, Z.; Kosek, M.N.; Rogawski, E.T.; Petri, W.; Bose, A.; Mduma, E.; Maciel, B.L.L.; et al. Relationships among Common Illness Symptoms and the Protective Effect of Breastfeeding in Early Childhood in MAL-ED: An Eight-Country Cohort Study. Am. J. Trop. Med. Hyg. 2018, 98, 904–912. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. World Health Organization. The World Health Organization’s Infant Feeding Recommendation. 2002. Available online: http://www.who.int/nutrition/topics/infantfeeding_recommendation/en/ (accessed on 10 November 2016).
  35. Tuon, F.F.; Gondolfo, R.B.; Cerchiari, N. Human-to-human transmission of Brucella—A systematic review. Trop. Med. Int. Health 2017, 22, 539–546. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. World Health Organization. Acceptable Medical Reasons for Use of Breastmilk Substitutes. Available online: https://www.who.int/nutrition/publications/infantfeeding/WHO_NMH_NHD_09.01/en/ (accessed on 29 November 2019).
  37. Pasquier, A.; Alais, S.; Roux, L.; Thoulouze, M.I.; Alvarez, K.; Journo, C.; Dutartre, H.; Mahieux, R. How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy. Front. Microbiol. 2018, 9, 278. [Google Scholar] [CrossRef] [PubMed]
  38. World Health Organisation. Measles Fact Sheet. Available online: https://www.who.int/news-room/fact-sheets/detail/measles (accessed on 20 November 2019).
  39. World Health Organisation. Measles and Rubella Surveillance Data. Available online: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/ (accessed on 1 December 2019).
  40. Government of Samoa. Measles Outbreak Update November 20 (Travellers Health Alert). Available online: www.health.gov.au (accessed on 1 December 2019).
  41. Penman, B.S.; Gupta, S.; Shanks, G.D. Rapid mortality transition of Pacific Islands in the 19th century. Epidemiol. Infect. 2017, 145, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Science, M.; Savage, R.; Severini, A.; McLachlan, E.; Hughes, S.L.; Arnold, C.; Richardson, S.; Crowcroft, N.; Deeks, S.; Halperin, S.; et al. Measles Antibody Levels in Young Infants. Pediatrics 2019, 144. [Google Scholar] [CrossRef] [PubMed]
  43. Silfverdal, S.A.; Ehlin, A.; Montgomery, S.M. Breast-feeding and a subsequent diagnosis of measles. Acta Paediatr. 2009, 98, 715–719. [Google Scholar] [CrossRef]
  44. Dorea, J.G. Breastfeeding is an essential complement to vaccination. Acta Paediatr. 2009, 98, 1244–1250. [Google Scholar] [CrossRef]
  45. Mina, M.J.; Metcalf, C.J.E.; de Swart, R.L.; Osterhaus, A.; Grenfell, B.T. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015, 348, 694–699. [Google Scholar] [CrossRef] [Green Version]
  46. Government of Canada. Measles Vaccine: Canadian Immunization Guide. Available online: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-12-measles-vaccine.html#p4c11a5 (accessed on 30 November 2019).
  47. Binns, C.; Low, W.Y. Zika: Where Are You? Asia Pac. J. Public Health Asia Pac. Acad. Consort. Public Health 2019, 31, 272–274. [Google Scholar] [CrossRef] [Green Version]
  48. Sampieri, C.L.; Montero, H. Breastfeeding in the time of Zika: A systematic literature review. PeerJ 2019, 7, e6452. [Google Scholar] [CrossRef]
  49. World Health Organisation. Infant Feeding in Areas of Zika Virus Transmission. Available online: https://apps.who.int/iris/bitstream/handle/10665/204473/WHO_ZIKV_MOC_16.5_eng.pdf?sequence=1 (accessed on 29 November 2019).
  50. Moller, A.B.; Petzold, M.; Chou, D.; Say, L. Early antenatal care visit: A systematic analysis of regional and global levels and trends of coverage from 1990 to 2013. Lancet Glob. Health 2017, 5, e977–e983. [Google Scholar] [CrossRef] [Green Version]
  51. Fowler, M.G.; Flynn, P.; Aizire, J. What is new in perinatal HIV prevention? Curr. Opin. Pediatr. 2018, 30, 144–151. [Google Scholar] [CrossRef] [PubMed]
  52. Ha, T.T.T.; Anh, N.M.; Bao, N.H.; Tuan, P.L.; Caridha, R.; Gaseitsiwe, S.; Hien, N.T.; Cam, P.D.; Ehrnst, A. HIV-1 mother-to-child transmission, post-test counselling, and antiretroviral prophylaxis in Northern Viet Nam: A prospective observational study. Scand. J. Infect. Dis. 2012, 44, 866–873. [Google Scholar] [CrossRef] [PubMed]
  53. Binns, C.; Low, W.Y. Hepatitis Requires Public Health Action. Asia Pac. J. Public Health Asia Pac. Acad. Consort. Public Health 2017, 29, 348–350. [Google Scholar] [CrossRef] [Green Version]
  54. Qiu, L.; Binns, C.W.; Zhao, Y.; Zhang, K.; Xie, X. Hepatitis B and breastfeeding in Hangzhou, Zhejiang Province, People’s Republic of China. Breastfeed. Med. 2010, 5, 109–112. [Google Scholar] [CrossRef]
  55. Chen, X.R.; Chen, J.; Wen, J.; Xu, C.Y.; Zhang, S.; Zhou, Y.H.; Hu, Y.L. Breastfeeding Is Not a Risk Factor for Mother-to-Child Transmission of Hepatitis B Virus. PLoS ONE 2013, 8, e55303. [Google Scholar] [CrossRef] [Green Version]
  56. World Health Organisation. Hepatitis C. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c (accessed on 15 December 2019).
  57. Hanafiah, K.M.; Groeger, J.; Flaxman, A.D.; Wiersma, S.T. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57, 1333–1342. [Google Scholar] [CrossRef]
  58. Bernstein, H.B.; Dunkelberg, J.C.; Leslie, K.K. Hepatitis C in Pregnancy in the Era of Direct-acting Antiviral Treatment: Potential Benefits of Universal Screening and Antepartum Therapy. Clin. Obstet. Gynecol. 2018, 61, 146–156. [Google Scholar] [CrossRef]
  59. Centers for Disease Control and Prevention. Hepatitis C. Available online: https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/hepatitis.html (accessed on 1 December 2019).
  60. Einsiedel, L.J.; Pham, H.; Woodman, R.J.; Pepperill, C.; Taylor, K.A. The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community. Med. J. Aust. 2016, 205, 305–309. [Google Scholar] [CrossRef]
  61. Yamada, T.; Togashi, T.; Tsutsumi, H.; Imamura, M.; Okubo, H.; Okabe, M.; Takamuro, N.; Tashiro, K.; Yano, K.; Yamamoto, N.; et al. Prevalence of human T-lymphotropic virus type 1 carriers among pregnant women in Hokkaido, Japan. Microbiol. Immunol. 2014, 58, 427–431. [Google Scholar] [CrossRef] [Green Version]
  62. Condon, J.R.; Armstrong, B.K.; Barnes, T.; Zhao, Y.J. Cancer incidence and survival for indigenous Australians in the northern territory. Aust. N. Z. J. Public Health 2005, 29, 123–128. [Google Scholar] [CrossRef] [PubMed]
  63. Talukder, M.R.R.; Walley, R.; Pham, H.; Schinke, S.; Woodman, R.; Wilson, K.; Sajiv, C.; Einsiedel, L. Higher human T-cell leukaemia virus type 1 (HTLV-1) proviral load is associated with end-stage kidney disease in Indigenous Australians: Results of a case-control study in central Australia. J. Med. Virol. 2019, 91, 1866–1872. [Google Scholar] [CrossRef] [PubMed]
  64. Vandenplas, Y.; Blecker, U. Helicobacter pylori infection in children. Acta Paediatr. 1998, 87, 1105–1112. [Google Scholar] [CrossRef]
  65. Leja, M.; Grinberga-Derica, I.; Bilgilier, C.; Steininger, C. Review: Epidemiology of Helicobacter pylori infection. Helicobacter 2019, 24, e12635. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Azami, M.; Nasirkandy, M.P.; Mansouri, A.; Darvishi, Z.; Rahmati, S.; Abangah, G.; Dehghan, H.R.; Borji, M.; Abbasalizadeh, S. Global Prevalence of Helicobacter pylori Infection in Pregnant Women: A Systematic Review and Meta-analysis Study. Int. J. Womens Health Reprod. Sci. 2017, 5, 30–36. [Google Scholar] [CrossRef] [Green Version]
  67. Kitagawa, M.; Natori, M.; Katoh, M.; Sugimoto, K.; Omi, H.; Akiyama, Y.; Sago, H. Maternal transmission of Helicobacter pylori in the perinatal period. J. Obstet. Gynaecol. Res. 2001, 27, 225–230. [Google Scholar] [CrossRef] [PubMed]
  68. Yucel, O. Prevention of Helicobacter pylori infection in childhood. World J. Gastroenterol. 2014, 20, 10348–10354. [Google Scholar] [CrossRef] [PubMed]
  69. Asoba, G.N.; Sumbele, I.U.N.; Anchang-Kimbi, J.K.; Metuge, S.; Teh, R.N. Influence of infant feeding practices on the occurrence of malnutrition, malaria and anaemia in children ≤5 years in the Mount Cameroon area: A cross sectional study. 2019, 14, e0219386. [Google Scholar] [CrossRef] [Green Version]
  70. Brazeau, N.F.; Tabala, M.; Kiketa, L.; Kayembe, D.; Chalachala, J.L.; Kawende, B.; Lapika, B.; Meshnick, S.R.; Yotebieng, M. Exclusive Breastfeeding and Clinical Malaria Risk in 6-Month-Old Infants: A Cross-Sectional Study from Kinshasa, Democratic Republic of the Congo. Am. J. Trop. Med. Hyg. 2016, 95, 827–830. [Google Scholar] [CrossRef] [Green Version]
  71. Yooseph, S.; Kirkness, E.F.; Tran, T.M.; Harkins, D.M.; Jones, M.B.; Torralba, M.G.; O’Connell, E.; Nutman, T.B.; Doumbo, S.; Doumbo, O.K.; et al. Stool microbiota composition is associated with the prospective risk of Plasmodium falciparum infection. BMC Genom. 2015, 16. [Google Scholar] [CrossRef]
  72. Al-Taiar, A.; Hammoud, M.S.; Liu, C.Q.; Lee, J.K.F.; Lui, K.M.; Nakwan, N.; Isaacs, D. Neonatal infections in China, Malaysia, Hong Kong and Thailand. Arch. Dis. Child. Fetal Neonatal Ed. 2013, 98, F249–F255. [Google Scholar] [CrossRef] [Green Version]
  73. Raihana, S.; Dibley, M.J.; Rahman, M.M.; Tahsina, T.; Siddique, M.A.; Rahman, Q.S.; Islam, S.; Alam, A.; Kelly, P.J.; El Arifeen, S.; et al. Early initiation of breastfeeding and severe illness in the early newborn period: An observational study in rural Bangladesh. PLoS Med. 2019, 16, e1002904. [Google Scholar] [CrossRef] [PubMed]
  74. Khan, J.; Vesel, L.; Bahl, R.; Martines, J.C. Timing of Breastfeeding Initiation and Exclusivity of Breastfeeding During the First Month of Life: Effects on Neonatal Mortality and Morbidity-A Systematic Review and Meta-analysis. Matern. Child Health J. 2015, 19, 468–479. [Google Scholar] [CrossRef] [PubMed]
  75. Vazquez, D.C.; Garcia, S.S.; Renau, M.I.; Iglesias-Platas, I. Availability of Donor Milk for Very Preterm Infants Decreased the Risk of Necrotizing Enterocolitis without Adversely Impacting Growth or Rates of Breastfeeding. Nutrients 2019, 11, 1895. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Quigley, M.; Embleton, N.D.; McGuire, W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst. Rev. 2018, 6, CD002971. [Google Scholar] [CrossRef]
  77. Silano, M.; Milani, G.P.; Fattore, G.; Agostoni, C. Donor human milk and risk of surgical necrotizing enterocolitis: A meta-analysis. Clin. Nutr. 2019, 38, 1061–1066. [Google Scholar] [CrossRef]
  78. Centers for Disease Control and Prevention. Ten Great Public Health Achievements—United States, 1900–1999. Morb. Mortal. Wkly. Rep. 1999, 48, 241–243. [Google Scholar]
  79. Grassly, N.C.; Kang, G.; Kannpmann, B. Biological challenges to effective vaccines in the developing world. Philos. Trans. R. Soc. B Biol. Sci. 2015, 370. [Google Scholar] [CrossRef]
  80. Gad, R.F.; Dowling, D.A.; Abusaad, F.E.; Bassiouny, M.R.; Abd El Aziz, M.A. Oral Sucrose Versus Breastfeeding in Managing Infants’ Immunization-Related Pain A Randomized Controlled Trial. MCN Am. J. Matern. Child Nurs. 2019, 44, 108–114. [Google Scholar] [CrossRef]
  81. Johnston, C.; Campbell-Yeo, M.; Disher, T.; Benoit, B.; Fernandes, A.; Streiner, D.; Inglis, D.; Zee, R. Skin-to-skin care for procedural pain in neonates. Cochrane Database Syst. Rev. 2017, 2, CD008435. [Google Scholar] [CrossRef]
  82. Bergin, N.; Murtagh, J.; Philip, R.K. Maternal Vaccination as an Essential Component of Life-Course Immunization and Its Contribution to Preventive Neonatology. Int. J. Environ. Res. Public Health 2018, 15, 847. [Google Scholar] [CrossRef] [Green Version]
  83. Meng, Q.H.; Liu, Y.; Yu, J.Q.; Li, L.J.; Shi, W.; Shen, Y.J.; Li, L.; Zhan, S.N.; Yang, F.; Wang, Y.J.; et al. Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing. Sci. Rep. 2018, 8, 13021. [Google Scholar] [CrossRef] [PubMed]
  84. Maertens, K.; De Schutter, S.; Braeckman, T.; Baerts, L.; Van Damme, P.; De Meester, I.; Leuridan, E. Breastfeeding after maternal immunisation during pregnancy: Providing immunological protection to the newborn: A review. Vaccine 2014, 32, 1786–1792. [Google Scholar] [CrossRef] [PubMed]
  85. Verhasselt, V. Is infant immunization by breastfeeding possible? Philos. Trans. R. Soc. B Biol. Sci. 2015, 370. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Olsen, S.J.; Mirza, S.A.; Vonglokham, P.; Khanthamaly, V.; Chitry, B.; Pholsena, V.; Chitranonh, V.; Omer, S.B.; Moen, A.; Bresee, J.S.; et al. The Effect of Influenza Vaccination on Birth Outcomes in a Cohort of Pregnant Women in Lao PDR, 2014-2015. Clin. Infect. Dis. 2016, 63, 487–494. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Cleary, B.J.; Rice, U.; Eogan, M.; Metwally, N.; McAuliffe, F. 2009 A/H1N1 influenza vaccination in pregnancy: Uptake and pregnancy outcomes—A historical cohort study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014, 178, 163–168. [Google Scholar] [CrossRef] [PubMed]
  88. Marchant, A.; Sadarangani, M.; Garand, M.; Dauby, N.; Verhasselt, V.; Pereira, L.; Bjornson, G.; Jones, C.E.; Halperin, S.A.; Edwards, K.M.; et al. Maternal immunisation: Collaborating with mother nature. Lancet Infect. Dis. 2017, 17, E197–E208. [Google Scholar] [CrossRef]
  89. Schofield, F.D.; Tucker, V.M.; Westbrook, G.R. Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy. Br. Med. J. 1961, 2, 785–789. [Google Scholar] [CrossRef]
  90. Datta, S.S.; Barnabas, R.; Sitther, A.; Guarenti, L.; Toikilik, S.; Kariwiga, G.; Sui, G.P. Three cases of neonatal tetanus in Papua New Guinea lead to development of national action plan for maternal and neonatal tetanus elimination. West. Pac. Surveill. Response J. 2013, 4, 40–43. [Google Scholar] [CrossRef]
  91. Thwaites, C.L.; Beeching, N.J.; Newton, C.R. Maternal and neonatal tetanus. Lancet 2015, 385, 362–370. [Google Scholar] [CrossRef] [Green Version]
  92. U.S. Department of Health and Human Services. The Surgeon General’s Call to Action to Support Breastfeeding; Department of Health and Human Services Office of the Surgeon General: Washington, DC, USA, 2011.
  93. Henry, M.; Fouladkhah, A. Outbreak History, Biofilm Formation, and Preventive Measures for Control of Cronobacter sakazakii in Infant Formula and Infant Care Settings. Microorganisms 2019, 7, 77. [Google Scholar] [CrossRef] [Green Version]
  94. Teramoto, S.; Tanabe, Y.; Okano, E.; Nagashima, T.; Kobayashi, M.; Etoh, Y. A first fatal neonatal case of Enterobacter sakazakii infection in Japan. Pediatrics Int. 2010, 52, 312–313. [Google Scholar] [CrossRef] [PubMed]
  95. United Nations Children’s Fund (UNICEF). Every Child Alive: The Urgent Need to End All Newborn Deaths; UNICEF: Geneva, Switzerland, 2018. [Google Scholar]
  96. Dey, S.K.; Chisti, M.J.; Das, S.K.; Shaha, C.K.; Ferdous, F.; Farzana, F.D.; Ahmed, S.; Malek, M.A.; Faruque, A.S.; Ahmed, T.; et al. Characteristics of diarrheal illnesses in non-breast fed infants attending a large urban diarrheal disease hospital in Bangladesh. PLoS ONE 2013, 8, e58228. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Horta, B.; Victora, C. The Short Term Effects of Breastfeeding: A Systematic Review. Available online: http://www.who.int/maternal_child_adolescent/documents/breastfeeding_short_term_effects/en/ (accessed on 1 February 2018).
  98. United Nations Department of Economic and Social Affairs Population Division. World Population Prospects 2019: Highlights (ST/ESA/SER.A/423); UN DESA: New York, NY, USA, 2019. [Google Scholar]
  99. Victora, C.G.; Bahl, R.; Barros, A.J.; Franca, G.V.; Horton, S.; Krasevec, J.; Murch, S.; Sankar, M.J.; Walker, N.; Rollins, N.C.; et al. Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. Lancet 2016, 387, 475–490. [Google Scholar] [CrossRef] [Green Version]
  100. Morley, D. Paediatric Priorities in the Developing World; Butterworth: London, UK, 1976. [Google Scholar]
  101. Ebrahim, G.J. Infant feeding in the Third World. Postgrad Med. J. 1986, 62, 93–96. [Google Scholar] [CrossRef] [PubMed]
  102. Boix-Amoros, A.; Collado, M.C.; Van’t Land, B.; Calvert, A.; Le Doare, K.; Garssen, J.; Hanna, H.; Khaleva, E.; Peroni, D.G.; Geddes, D.T.; et al. Reviewing the evidence on breast milk composition and immunological outcomes. Nutr. Rev. 2019, 77, 541–556. [Google Scholar] [CrossRef] [PubMed]
  103. Admyre, C.; Johansson, S.M.; Qazi, K.R.; Filen, J.-J.; Lahesmaa, R.; Norman, M.; Neve, E.P.A.; Scheynius, A.; Gabrielsson, S. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 2007, 179, 1969–1978. [Google Scholar] [CrossRef]
  104. Agarwal, S.; Karmaus, W.; Davis, S.; Gangur, V. Immune Markers in Breast Milk and Fetal and Maternal Body Fluids: A Systematic Review of Perinatal Concentrations. J. Hum. Lact. 2011, 27, 171–186. [Google Scholar] [CrossRef]
  105. Ballard, O.; Morrow, A.L. Human Milk Composition Nutrients and Bioactive Factors. Pediatric Clin. N. Am. 2013, 60, 49–74. [Google Scholar] [CrossRef] [Green Version]
  106. Gay, M.C.L.; Koleva, P.T.; Slupsky, C.M.; du Toit, E.; Eggesbo, M.; Johnson, C.C.; Wegienka, G.; Shimojo, N.; Campbell, D.E.; Prescott, S.L.; et al. Worldwide Variation in Human Milk Metabolome: Indicators of Breast Physiology and Maternal Lifestyle? Nutrients 2018, 10, 1151. [Google Scholar] [CrossRef] [Green Version]
  107. Binns, C.W.; Lee, M.K. Exclusive breastfeeding for six months: The WHO six months recommendation in the Asia Pacific Region. Asia Pac. J. Clin. Nutr. 2014, 23, 344–350. [Google Scholar] [CrossRef]
  108. Binns, C.; Lee, M.K.; Kagawa, M.; Low, W.Y.; Scott, J.; Lee, A.; Zerfas, A.; Maycock, B.; Qiu, L.; Yusuff, A.; et al. Infant Feeding Guidelines for the Asia Pacific Region. Asia Pac. J. Public Health 2018. [Google Scholar] [CrossRef] [PubMed]
  109. National Health and Medical Research Council. Infant Feeding Guidelines for Health Workers. Available online: www.nhmrc.gov.au (accessed on 23 September 2019).
  110. Troeger, C.; Colombara, D.V.; Rao, P.C.; Khalil, I.A.; Brown, A.; Brewer, T.G.; Guerrant, R.L.; Houpt, E.R.; Kotloff, K.L.; Misra, K.; et al. Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years. Lancet Glob. Health 2018, 6, E255–E269. [Google Scholar] [CrossRef] [Green Version]
  111. Gaufin, T.; Tobin, N.H.; Aldrovandi, G.M. The importance of the microbiome in pediatrics and pediatric infectious diseases. Curr. Opin. Pediatrics 2018, 30, 117–124. [Google Scholar] [CrossRef] [PubMed]
  112. Tang, W.H.W.; Li, D.Y.; Hazen, S.L. Dietary metabolism, the gut microbiome, and heart failure. Nat. Rev. Cardiol. 2019, 16, 137–154. [Google Scholar] [CrossRef] [PubMed]
  113. Zmora, N.; Suez, J.; Elinav, E. You are what you eat: Diet, health and the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 35–56. [Google Scholar] [CrossRef] [PubMed]
  114. Dong, T.S.; Gupta, A. Influence of Early Life, Diet, and the Environment on the Microbiome. Clin. Gastroenterol. Hepatol. 2019, 17, 231–242. [Google Scholar] [CrossRef]
  115. Olofin, I.; McDonald, C.M.; Ezzati, M.; Flaxman, S.; Black, R.E.; Fawzi, W.W.; Caulfield, L.E.; Danaei, G.; Nutrition Impact Model Study. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLoS ONE 2013, 8, e64636. [Google Scholar] [CrossRef] [Green Version]
  116. Hetzner, N.M.; Razza, R.A.; Malone, L.M.; Brooks-Gunn, J. Associations among feeding behaviors during infancy and child illness at two years. Matern. Child Health J. 2009, 13, 795–805. [Google Scholar] [CrossRef]
  117. Bass, J.L.; Gartley, T.; Kleinman, R. World Health Organization Baby-Friendly Hospital Initiative Guideline and 2018 Implementation Guidance. JAMA Pediatrics 2019, 173, 93–94. [Google Scholar] [CrossRef]
  118. Wouk, K.; Tully, K.P.; Labbok, M.H. Systematic Review of Evidence for Baby-Friendly Hospital Initiative Step 3. J. Hum. Lact. 2017, 33, 50–82. [Google Scholar] [CrossRef]
  119. UNICEF. Mother-Infant Early Skin-to-Skin Contact Implementing Baby Friendly Standards Resources. Available online: https://www.unicef.org.uk/babyfriendly/baby-friendly-resources/implementing-standards-resources/skin-to-skin-contact/ (accessed on 21 November 2019).
  120. Abdulghani, N.; Edvardsson, K.; Amir, L.H. Worldwide prevalence of mother-infant skin-to-skin contact after vaginal birth: A systematic review. PLoS ONE 2018, 13, e0205696. [Google Scholar] [CrossRef] [PubMed]
  121. Karall, D.; Ndayisaba, J.P.; Heichlinger, A.; Kiechl-Kohlendorfer, U.; Stojakovic, S.; Leitner, H.; Scholl-Burgi, S. Breast-feeding Duration: Early Weaning-Do We Sufficiently Consider the Risk Factors? J. Pediatric Gastroenterol. Nutr. 2015, 61, 577–582. [Google Scholar] [CrossRef] [PubMed]
Figure 1. PRISMA diagram of selection of studies reviewed in this paper.
Figure 1. PRISMA diagram of selection of studies reviewed in this paper.
Ijerph 17 00186 g001
Table 1. Studies of Breastfeeding and Infection in Infants in Asia.
Table 1. Studies of Breastfeeding and Infection in Infants in Asia.
CountryAuthorStudy SizeDesignAge MonthsBreastfeeding ClassificationOutcome MeasureResults
Eight Countries incl Nepal India, Bangladesh PakistanRichard MALED 20181731Cohort0–24EBF compared to ABFaRR diarr 0–2M0.58 0.44, 0.76
aRR RespNS
aRR diarr 3–5M0.83 0.75, 0.93
aRR Resp0.81 0.68, 0.98
MaldivesRaheem 2017458Cohort0–6Predominant BF 6/12 Y = 153, N = 305ARTI aOR0.45 (0.24–0.84)
Diarrhoea aOR0.31 (0.10–0.90)
China (urban)Yu [20] 2016682Cohort0–6Any BF 1/12 (Y = 607 N = 75)aOR LRTI (<6/12)0.479(0.263-0.872)
Vietnam (rural)Hanieh 20151049Cohort0–6Exclusive BF at 6 weeks (32.8%)Diarrhoea OR0.37 (0.15 to 0.88)
Pneumonia OR0.39 (0.20,0.75)
India RuralPanda 2014696Cohort0–6EBF compared to ABFaOR diarr0.49 (0.27, 0.90)
Bangladesh RuralMihrshahi 2008351Cohort0–6EBF compared to Partial BFaOR diarr0.29 (0.12, 0.68
aOR ARI0.4 (0.21, 0.75)
Bangladesh UrbanArifeen 20011677Cohort0–12Predominant breastfeeding compared to partial or noneAll deaths aHR0.45 (0.29, 0.69)
ARI deaths0.42(0.20, 0.88)
Diarrhoea0.25 (0.09,0.68)
PhilippinesYoon 19969942Cohort0–12Not BF compared to Breastfed Death rates 0–5 monthsaRR diarr0.10 (0.25,0.04)
aRR ALRINS
aRR ALRI0.17 (0.56–0.05)
PhilippinesHengstermann 2010399Case control0–6Risk of hospitalisation Exclusive breastfeeding & Formula fedAny Infection aOR0.29 (0.17,0.48)
Diarrhoea aOR0.05 (0.02,0.15)
Pneumonia aOR0.36 (0.19,0.66)
China (rural)Li 2019 [21]1802Cross sect6–12Any BF = 1049 Not BF = 753) Illness in past monthDiarrhoea p < 0.01BF 33%, No BF 42%
Cough p = 0.03BF 43% NoBF49%
Bangladesh nationalKhan 20171918DHS cross sectional0–6EBF T 0–2 MaOR diarr0.20 (0.10, 0.32)
aOR ARI0.42 (0.31, 0.79)
EBF T 2–4 MaOR diarr0.32 (0.20, 0.47
aOR ARI0.71 (0.57, 0.90)
EBF T 4–6 MaOR diarr0.43 (0.31, 0.53)
aOR ARI0.84 (0.64, 0.96)
China (urban)Cai 20161654Cross sect0–12Exclusive BF Mixed Exc FormulaHospitalisation EBF compared to Exc FormulaRespiratory illness
OR 0.69 (0.50, 0.96)
Bangladesh RuralMihrshahi 20071633 DHScross section0–3EBF 0–3 M compared otheraOR diarr0.69 (0.49–0.98)
aOR ARI0.69 (0.54–0.88)
IMR = infant mortality rate, HR = hazard ratio, aOR = adjusted odds ratio, ARI = acute respiratory infection, M = months, DHS = Demographic and Health Survey. ALRI = acute lower respiratory infection, diarrh = diarrhoeal diseae, EBF = Exclusive breastfeeding, EFF = Exclusive formula feeding, PBF = Predominant breastfeeding, ABF = Any breastfeeding, * = P < 0.05. Note in the Arifeen study deaths <4 days of age were not included to exclude birth trauma and fatal congenital abnormalities. In the Khan study ‘T’ indicates that Exclusive breastfeeding was terminated 2, 4 or 6 months as indicated. The references used in compiling Table 1 are: [20,21,22,23,24,25,26,27,28,29,30,31,32,33].

Share and Cite

MDPI and ACS Style

Lee, M.K.; Binns, C. Breastfeeding and the Risk of Infant Illness in Asia: A Review. Int. J. Environ. Res. Public Health 2020, 17, 186. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17010186

AMA Style

Lee MK, Binns C. Breastfeeding and the Risk of Infant Illness in Asia: A Review. International Journal of Environmental Research and Public Health. 2020; 17(1):186. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17010186

Chicago/Turabian Style

Lee, Mi Kyung, and Colin Binns. 2020. "Breastfeeding and the Risk of Infant Illness in Asia: A Review" International Journal of Environmental Research and Public Health 17, no. 1: 186. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17010186

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop